Date:
Location: ,

Forward This Message to a Friend

* = Required Fields

 

*

 

*

Enter multiple addresses on separate lines or separate them with commas.
(Note: We respect your privacy, addresses you enter below will be added to your Address Book, but will not be used by the organization. For further information, see our Privacy Policy.)

  
   Please leave this field empty

A copy of the message that follows will be sent to the addresses you specify:

 

View Online

Donate

 
 

ZERO and Us TOO Join Forces

Exciting News: ZERO + UsToo

Breaking news for the prostate cancer community, ZERO is merging with another impactful and inspiring prostate cancer nonprofit, Us TOO International. The coming together of these two organizations comes at an urgent time in the fight against prostate cancer with nearly 250,000 men who will be diagnosed with prostate cancer this year alone.

The unification of these two leading prostate cancer organizations will provide a new comprehensive support system for prostate cancer patients, survivors, and caregivers. In addition, the merged entity will increase prostate cancer awareness and advance research and access to care through a united advocacy platform.

The merger will be finalized this September during Prostate Cancer Awareness Month, the perfect time to kick off and celebrate this new patient-centric powerhouse. For more information, read the press release.

Read the Press Release
dividing line

April is National Minority Health Month

AutoNation: Let's drive out prostate cancer

April marks National Minority Health Month and ZERO is thrilled to have AutoNation as a champion in the fight against prostate cancer. This month, AutoNation is partnering with ZERO to encourage men at high-risk to get screened. They have added ZERO to their "DRVPNK" campaign, which partners with cancer charities from coast to coast to raise and donate millions of dollars to cancer research and treatment.

Prostate cancer survivor and ZERO Champion Chas Rodgers is one of the faces of AutoNation's campaign. We are grateful to have AutoNation's help raise both awareness and funds all month long. For more on National Minority Health Month and the importance of early detection for Black men due to a double risk of diagnosis and death from prostate cancer, follow ZERO online.

Follow ZERO on Facebook
dividing line

Vote on the 2021 ZERO Prostate Cancer Run/Walk Series Shirt!

ZERO Run/Walk crowd running

This fall, ZERO Prostate Cancer Run/Walks are coming to a city near you! This year will be even more special as we ZERO out prostate cancer in-person together. To celebrate the return of in-person Run/Walks, cast your vote on this year's t-shirt design. This design will be worn at nearly 40 Run/Walks around the country. The winning design will be announced this summer. Vote now and ask your friends and family to do the same! Voting closes on April 23.

Vote Here
dividing line

Increase Your Impact

Become a Monthly Donor

With prostate cancer cases on the rise this year, more patients and families than ever need your help. By giving just a few dollars a month, you could help a patient get access to direct assistance, care, support, community, and resources that can make a life-changing difference.

As a member of this inspiring community, you'll receive special benefits and regular updates about how your support is improving lives. No donation is too small, every dollar you give will show a prostate cancer patient they are not alone. Become a monthly donor today by clicking "monthly" on the donate form below! Thank you for your passion and generosity.

Help a man every month
dividing line

Clinical Trials

Medicine Image

Many patients are unaware of clinical trials and/or have questions about clinical trials.

That's why ZERO sat down to answer some of the most common questions people have about clinical trials.

(This content is provided in partnership with Bristol Myers Squibb.)

Read the Blog
dividing line

Prostate Cancer Press

ZERO in the News

In case you missed it, check out ZERO community in the news:

  • Caregivers Athena and Helen share their unique experiences in this podcast
  • ZERO Champion Stephanie Mueller celebrates her recent Impact Award
  • AFRO News recaps Cal Ripken's Mission Speech at the 2021 ZERO Prostate Cancer Summit
  • Advocate Kenny Kellner reflects on his Summit experience
  • Read about ZERO360 and how it helps patients and families

dividing line

Upcoming Webinars

Upcoming Webinars

Register for these free, upcoming webinars.

ZERO - The End of Prostate Cancer:

Us TOO:

AnCan (Answer Cancer Foundation):

dividing line

Champions Corner

The McElhaneys

Mac Attacks Prostate Cancer

David (Mac) McElhaney is a new ZERO Champion from Alabama. A prostate cancer survivor, he started his own support group to help other men understand the challenges of prostate cancer. An accomplished author, Mac wrote a book about his prostate cancer experience, and his working with his community and physicians to bring a ZERO Run/Walk to Huntsville! Welcome to the ZERO family, Mac! » Apply to be a Champion like Mac

Clinical Trials

Merck clinical trials image

Now Registering Metastatic Prostate Cancer Patients

There are many investigational clinical trials of metastatic prostate cancer being conducted at this time by Merck. These studies are trying to find out if investigational medications are safe and work to slow down or stop the growth of metastatic prostate cancer. » Register for a Merck clinical trial (This content is provided in partnership with Merck.)

Clinical Trials

patient photo

Clinical Trials

​Clinical trials are a great way for prostate cancer patients to help in the fight against cancer. Our partners at Bristol Myers Squibb are currently enrolling advanced prostate cancer patients in clinical trial studies now. » Sign up today (This content is provided in partnership with Bristol Myers Squibb.)

COVID-19

Needle in Medicine vial

COVID-19 Vaccine & You

Many patients and families impacted by prostate cancer are wondering what the COVID-19 vaccine means for them. Watch this video to learn more about how the vaccine affects the cancer community. » Watch Now

Clinical Trials

Patient image

Prostate Cancer Research Study

The TALAPRO-2 clinical trial is enrolling men with metastatic castration-resistant prostate cancer to study a potential treatment. More information is available. » Learn more (This content is provided in partnership with Pfizer Oncology.)

dividing line
 
Make sure you keep getting email from ZERO. Add info@zerocancer.org to your address book or safe-sender list.
 
 

515 King Street - Suite 310
Alexandria, VA 22314
202-463-9455

view this email online

privacy policy

email preferences

 

 

This email was intended for

 

© 2024 ZERO Prostate Cancer. All rights reserved. ZERO is a 501(c)(3) non-profit organization.